International research involving a Monash University biologist shows that bacteriophage therapy -- a process whereby bacterial viruses attack and destroy specific strains of bacteria -- can be used successfully to treat systemic, multidrug-resistant bacterial infections.
The latest research, published in Antimicrobial Agents & Chemotherapeutics has wide implications for antibiotic resistance, which the World Health Organization has described as a major threat to public health.
One of the study's authors, Dr. Jeremy Barr from the Monash School of Biological Sciences, said that antibiotics can no longer be solely relied upon to halt the spread of antibiotic-resistant bacterial infections.
"Last year we saw a patient die in the U.S. from a bacterial infection resistant to all antibiotics. 'Pan-resistant' strains of bacterial infection are inevitable," Barr said.
Barr's lab at Monash University studies bacteriophage -- specialist viruses that only infect and kill bacteria -- and investigates their role and function in the human body.
Bacteriophage (or phage for short) are the most abundant and diverse microbe found in the body. Phages control and manipulate bacterial populations, prevent infection and disease and have important roles in regulating the microbiome and body that have not yet been fully elucidated.
The latest research, published in the prestigious Antimicrobial Agents & Chemotherapeutics, follows the remarkable case of a 69-year-old diabetic in the US who was treated successfully with bacteriophages after being infected with a life-threatening multidrug-resistant strain of Acinetobacter baumannii.
The study is significant because it is the first time bacteriophage therapy has been used in the U.S. to treat a patient who had an antibiotic-resistant, blood stream infection.
"Antibiotics were no longer working, and this infection would have very likely killed him had we not intervened."
The study was led by Dr. Robert Schooley from the University of California San Diego.
Source: Monash University
Avian Flu Risks in Veterinary Practice: Protecting Those on the Frontlines
January 6th 2025Veterinarians, technicians, and veterinarian infection preventionists face risks from H5N1 avian flu when handling farm animals or exposed wildlife. Learn key prevention strategies, PPE recommendations, and emerging challenges.
Understanding the True Threat: Richard Webby, PhD, on H5N1 Avian Flu and Its Human Impact
January 3rd 2025Richard Webby, PhD, the director of the World Health Organization (WHO) Collaborating Centre or Studies on the Ecology of Influenza in Animals and Birds, discusses the evolving dynamics of H5N1 avian flu, its variants, and the low risk to humans while emphasizing vigilance among health care professionals.
Top 7 Infection Control Today Articles of 2024: Insights and Innovations
December 30th 2024From advanced sterilization methods to combating antimicrobial resistance, Infection Control Today’s top articles of 2024 delivered actionable strategies for safer healthcare environments and improved patient outcomes.
Revolutionizing Infection Prevention: How Fewer Hand Hygiene Observations Can Boost Patient Safety
December 23rd 2024Discover how reducing hand hygiene observations from 200 to 50 per unit monthly can optimize infection preventionists' time, enhance safety culture, and improve patient outcomes.
Redefining Competency: A Comprehensive Framework for Infection Preventionists
December 19th 2024Explore APIC’s groundbreaking framework for defining and documenting infection preventionist competency. Christine Zirges, DNP, ACNS-BC, CIC, FAPIC, shares insights on advancing professional growth, improving patient safety, and navigating regulatory challenges.